title: Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia.
abstract: Schizophrenia is considered a brain disease with a quite heterogeneous clinical presentation. Studies in schizophrenia have yielded a wide array of correlations between structural and functional brain changes and clinical and cognitive symptoms. Reductions of grey matter volume (GMV) in the prefrontal and temporal cortex have been described which are crucial for the development of positive and negative symptoms and impaired working memory (WM). Associations between GMV reduction and positive and negative symptoms as well as WM impairment were assessed in schizophrenia patients (symptomatology in 34, WM in 26) and compared to healthy controls (36 total, WM in 26). GMV was determined by voxel-based morphometry and its relation to positive and negative symptoms as well as WM performance was assessed. In schizophrenia patients, reductions of GMV were evident in anterior cingulate cortex, ventrolateral prefrontal cortex (VLPFC), superior temporal cortex, and insula. GMV reductions in the superior temporal gyrus (STG) were associated with positive symptom severity as well as WM impairment. Furthermore, the absolute GMV of VLPFC was strongly related to negative symptoms. These predicted WM performance as well as processing speed. The present results support the assumption of two distinct pathomechanisms responsible for impaired WM in schizophrenia: (1) GMV reductions in the VLPFC predict the severity of negative symptoms. Increased negative symptoms in turn are associated with a slowing down of processing speed and predict an impaired WM. (2) GMV reductions in the temporal and mediofrontal cortex are involved in the development of positive symptoms and impair WM performance, too.
authors.affiliation: Department of Psychiatry, Otto-von-Guericke University Magdeburg, Germany.
authors.forename: Kathrin C
authors.initials: KC
authors.lastname: Zierhut
authors.forename: Anna
authors.initials: A
authors.lastname: Schulte-Kemna
authors.forename: Jörn
authors.initials: J
authors.lastname: Kaufmann
authors.forename: Johann
authors.initials: J
authors.lastname: Steiner
authors.forename: Bernhard
authors.initials: B
authors.lastname: Bogerts
authors.forename: Kolja
authors.initials: K
authors.lastname: Schiltz
mesh_terms: D000328:Adult; D017668:Age of Onset; D000704:Analysis of Variance; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D038801:International Classification of Diseases; D016014:Linear Models; D008279:Magnetic Resonance Imaging; D008297:Male; D008569:Memory Disorders / Q000209:etiology / Q000473:pathology* / Q000523:psychology*; D008570:Memory, Short-Term / Q000502:physiology*; D010775:Photic Stimulation; D017397:Prefrontal Cortex / Q000473:pathology; D011597:Psychomotor Performance / Q000502:physiology; D011930:Reaction Time / Q000502:physiology; D012563:Schizophrenia, Paranoid / Q000150:complications / Q000473:pathology* / Q000523:psychology*; D013702:Temporal Lobe / Q000473:pathology
chemical_list: D014150:Antipsychotic Agents